Institution

Insel Gruppe AG, University Hospital Bern

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · OBSERVATIONAL STUDY

Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study

ClinicalTrials.gov

This is a registry record for an ongoing observational study with no results reported; recruitment is active and follow-up extends to 10 years, so evidence generation is not yet complete.

PreliminaryHeart Failure NCT07276139 Arrhythmias, Cardiac

Reported

Planned enrollment4500

Primary outcome measureNumber of participants developing PICM, def…

Follow-up durationup to 10 years

AUG 19, 2026 · INTERVENTIONAL STUDY

GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

ClinicalTrials.gov

This is a registered interventional study not yet recruiting with no posted results; it represents planned work to test whether semaglutide plus counselling improves alcohol abstinence versus counselling alone in patients with obesity and fatty liver disease.

PreliminaryNCT06546384 Alcohol Use Disorder Adiposity

Reported

Planned enrollment64

Study duration per patient16 weeks

Primary outcome measureProportion of patients achieving total alco…